This novel evidence provides a rationale for future assessment of CTRC, OSM, and MMP-10 in larger prospective studies on cardiorespiratory risk in patients with COPD and CB that include patients with varying exacerbation severity. The gene discussed is MMP10; the disease is chronic obstructive pulmonary disease.